Unilateral mastectomy removes the breast with cancer. Bilateral removes both, the diseased breast and the healthy one on the other side. Removing the healthy breast is clinically justified when a BRCA1 or BRCA2 mutation is confirmed, when cancer is found in both breasts simultaneously or when the contralateral risk is high enough to warrant removal at the same time. Without one of these indications, bilateral mastectomy is a personal decision. It’s supported after counselling but it’s not driven by the cancer itself.
According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India,
“Bilateral mastectomy is right for specific patients and wrong for others. Genetics, pathology and what the patient values all go into that conversation. It doesn’t get decided quickly.”
Want to know whether unilateral or bilateral mastectomy fits your situation?
When Is Removing One Breast the Right Call?
For most patients, unilateral mastectomy is the appropriate operation and the evidence supports it clearly.
- One-Sided Disease, No Mutation: Patients without a BRCA mutation who have cancer in one breast have the affected side removed and the other breast monitored annually with mammography and breast cancer treatment guidelines consistently support this over prophylactic removal of a healthy breast in average-risk women.
- No Survival Gain From Removing the Healthy Breast: Studies in average-risk patients show bilateral mastectomy doesn’t improve survival over unilateral mastectomy with regular surveillance, which means removing a healthy breast in this group adds surgical risk without adding oncological benefit.
- Less Surgery Means Faster Recovery: One operative site, shorter theatre time, lower complication rates and an earlier start to adjuvant chemotherapy or radiation compared to bilateral surgery performed in the same session.
- Reconstruction Stays Manageable: Single-sided reconstruction whether through implant or flap is less physiologically demanding, involves one donor site and carries a more predictable recovery compared to bilateral reconstruction done simultaneously at the time of mastectomy.
Unilateral mastectomy with structured follow-up is the right default for average-risk patients with cancer on one side only.
Unilateral vs Bilateral Mastectomy: When Each Is Used
|
Unilateral Mastectomy |
Bilateral Mastectomy |
|
|
Indication |
Single breast cancer, average risk |
BRCA mutation, bilateral cancer |
|
Healthy Breast |
Kept and monitored annually |
Removed in same session |
|
Survival Benefit |
Equivalent in average-risk patients |
Clear benefit in BRCA carriers |
|
Surgery Duration |
Shorter |
Significantly longer |
|
Reconstruction |
One-sided, less complex |
Bilateral, more demanding |
|
Patient Choice |
Standard recommendation |
Supported when risk-justified |
- BRCA Carriers Have a Real Clinical Reason: A confirmed BRCA1 or BRCA2 mutation puts lifetime risk at 60 to 80 percent in both breasts and bilateral mastectomy cuts that by over 90 percent, making it a medically grounded rather than purely elective decision when a carrier chooses it.
- Simultaneous Bilateral Cancer Changes the Plan Entirely: When cancer is found in both breasts at the same diagnosis, bilateral mastectomy is the logical surgical response and robotic cancer surgery or conventional bilateral mastectomy is planned with reconstruction discussed alongside it from the start.
- Patient Preference Without Mutation Is Still Valid: Women who want bilateral mastectomy for peace of mind, without a genetic mutation, are not refused. They receive detailed counselling first so the decision is informed, not fear-driven.
- Both Sides at Once Adds Real Complexity: Bilateral reconstruction in a single session is a long operation with a significant recovery burden and patients need to understand what they’re committing to physically before the decision is locked in.
The right mastectomy type depends on the full clinical picture and for more on what reconstruction involves after mastectomy, our blog on breast reconstruction covers this in detail.
Why Choose Dr. Sandeep Nayak for Breast Cancer Treatment?
Dr. Sandeep Nayak brings 24 years of surgical oncology experience, DNB qualifications in Surgical Oncology and General Surgery and a fellowship in Laparoscopic and Robotic Onco-Surgery to every mastectomy decision including unilateral and bilateral cases with reconstruction planning from the first surgical consultation. He heads Oncology Services across Karnataka and leads breast cancer surgery at KIMS Hospital, Bangalore, with originator credits for RABIT and over 25 published clinical studies. Patients wanting clarity on which mastectomy type fits their clinical and genetic profile are seen here with every decision going through tumour board review. Call +91 8104310753 to book your consultation.
Frequently Asked Questions
When is bilateral mastectomy a medical requirement?
Bilateral mastectomy is clinically indicated in confirmed BRCA1 or BRCA2 mutation carriers and patients diagnosed with synchronous cancer in both breasts.
Does removing both breasts improve survival in average-risk patients?
Bilateral mastectomy doesn’t improve survival over unilateral mastectomy with regular surveillance in average-risk patients without a genetic mutation.
Can a woman without a BRCA mutation choose bilateral mastectomy?
Informed patient choice for bilateral mastectomy is supported after counselling confirms the patient understands there is no survival benefit in average-risk cases.
How does bilateral mastectomy affect reconstruction?
Bilateral reconstruction adds considerable operative complexity and recovery time and is discussed in full with the patient before any surgical plan is confirmed.
Reference Links-
- National Cancer Institute — Mastectomy for Breast Cancer
- World Health Organization — Breast Cancer Treatment
- Disclaimer: The information shared in this content is for educational purposes and not for promotional use.
